Michael S. Poirier - Net Worth and Insider Trading
Michael S. Poirier Net Worth
The estimated net worth of Michael S. Poirier is at least $1,793 dollars as of 2024-12-28. Michael S. Poirier is the Chairman and CEO of Qualigen Therapeutics Inc and owns about 420 shares of Qualigen Therapeutics Inc (QLGN) stock worth over $1,793. Details can be seen in Michael S. Poirier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael S. Poirier has not made any transactions after 2022-06-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael S. Poirier
Michael S. Poirier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael S. Poirier owns 2 companies in total, including Ritter Pharmaceuticals Inc (RTTR) , and Qualigen Therapeutics Inc (QLGN) .
Click here to see the complete history of Michael S. Poirier’s form 4 insider trades.
Insider Ownership Summary of Michael S. Poirier
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RTTR | Ritter Pharmaceuticals Inc | 2020-06-06 | director & Chairman & President & CEO |
| QLGN | Qualigen Therapeutics Inc | 2022-06-22 | director & Chairman & President and CEO |
Michael S. Poirier Latest Holdings Summary
Michael S. Poirier currently owns a total of 1 stock. Michael S. Poirier owns 420 shares of Qualigen Therapeutics Inc (QLGN) as of June 22, 2022, with a value of $1,793.
Latest Holdings of Michael S. Poirier
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QLGN | Qualigen Therapeutics Inc | 2022-06-22 | 420 | 4.27 | 1,793 |
Holding Weightings of Michael S. Poirier
Michael S. Poirier Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael S. Poirier has made a total of 1 transactions in Qualigen Therapeutics Inc (QLGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Qualigen Therapeutics Inc is the acquisition of 60 shares on June 22, 2022, which cost Michael S. Poirier around $17,100.
Insider Trading History of Michael S. Poirier
- 1
Michael S. Poirier Trading Performance
GuruFocus tracks the stock performance after each of Michael S. Poirier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael S. Poirier is -49.45%. GuruFocus also compares Michael S. Poirier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael S. Poirier within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael S. Poirier's insider trading performs compared to the benchmark.
Performance of Michael S. Poirier
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.31 | | | | | |
| Relative Return to S&P 500(%) | -23.68 | | | | | |
Michael S. Poirier Ownership Network
Michael S. Poirier Owned Company Details
What does Ritter Pharmaceuticals Inc do?
Who are the key executives at Ritter Pharmaceuticals Inc?
Michael S. Poirier is the director & Chairman & President & CEO of Ritter Pharmaceuticals Inc. Other key executives at Ritter Pharmaceuticals Inc include 10 percent owner Sekisui Diagnostics, Llc , Vice President of Finance & CFO Christopher L. Lotz , and Vice President of Operations Shishir K. Sinha .
Ritter Pharmaceuticals Inc (RTTR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ritter Pharmaceuticals Inc (RTTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ritter Pharmaceuticals Inc (RTTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ritter Pharmaceuticals Inc (RTTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ritter Pharmaceuticals Inc Insider Transactions
Michael S. Poirier Mailing Address
Above is the net worth, insider trading, and ownership report for Michael S. Poirier. You might contact Michael S. Poirier via mailing address: 2042 Corte Del Nogal, Suite B, Carlsbad Ca 92011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
